TCRT Stock Update: Alaunos Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities

Alaunos Therapeutics Inc (TCRT) has a current stock price of $0.08. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.08 after opening at $0.069. The stock’s low for the day was $0.063, and it eventually closed at $0.07.

Alaunos Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $1.05 on 11/21/22, and the lowest price during that time was $0.06, recorded on 11/20/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of TCRT Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Alaunos Therapeutics Inc’s current trading price is -92.65% away from its 52-week high, while its distance from the 52-week low is 20.62%. The stock’s price range for this period has remained between $0.06 and $1.05. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.25 million for the day, which was noticeably higher compared to the shares’ average daily volume of 3.35 million over the last three months.

Financial Performance and Market Capitalization

Alaunos Therapeutics Inc (TCRT) has experienced a quarterly decline of -39.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.58M and boasts a workforce of 34 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2207, with a change in price of -0.4143. Similarly, Alaunos Therapeutics Inc recorded 2,706,978 in trading volume during the last 100 days, posting a change of -84.29%.

TCRT Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TCRT stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.

TCRT Stock Stochastic Average

As of today, the raw stochastic average of Alaunos Therapeutics Inc over the past 50 days is 15.43%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 31.07%. Additionally, the Stochastic %K and %D values for the company were 15.70% and 14.13%, respectively, over the past 20 days.

TCRT Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -88.11% this year. Over the last six months, there has been a stronger performance of -87.94%. The price of TCRT leaped by -25.63% during the last 30 days period. For the last 5-days stocks have slided -7.10%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts